Literature DB >> 27847301

Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.

Zohreh Nademi1, Mary A Slatter2, Christopher C Dvorak3, Benedicte Neven4, Alain Fischer4, Felipe Suarez5, Claire Booth6, Kanchan Rao7, Alexandra Laberko8, Julia Rodina8, Yves Bertrand9, Sylwia Kołtan10, Robert Dębski10, Terence Flood11, Mario Abinun2, Andrew R Gennery2, Sophie Hambleton2, Stephan Ehl12, Andrew J Cant2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27847301     DOI： 10.1016/j.jaci.2016.09.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  34 in total

1.  Hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Who, when, and how?

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2018-09-12       Impact factor: 10.793

2.  Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.

Authors:  Alexandra Laberko; Elvira Sultanova; Elena Gutovskaya; Irina Shipitsina; Larisa Shelikhova; Elena Kurnikova; Yakov Muzalevskii; Alexei Kazachenok; Dmitriy Pershin; Kirill Voronin; Anna Shcherbina; Michael Maschan; Alexey Maschan; Dmitry Balashov
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

Review 3.  Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

Authors:  Stuart G Tangye; Julia Bier; Anthony Lau; Tina Nguyen; Gulbu Uzel; Elissa K Deenick
Journal:  J Clin Immunol       Date:  2019-03-25       Impact factor: 8.317

Review 4.  Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

Authors:  Emma C Morris
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

5.  Thyroid Carcinoma in a Child with Activated Phosphoinositide 3-Kinase δ Syndrome: Somatic Effect of a Germline Mutation.

Authors:  Giorgia Bucciol; Lien Willems; Esther Hauben; Anne Uyttebroeck; Marijke Proesmans; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2017-06-11       Impact factor: 8.317

Review 6.  Targeted strategies directed at the molecular defect: Toward precision medicine for select primary immunodeficiency disorders.

Authors:  Luigi D Notarangelo; Thomas A Fleisher
Journal:  J Allergy Clin Immunol       Date:  2017-03       Impact factor: 10.793

Review 7.  Advances and highlights in primary immunodeficiencies in 2017.

Authors:  Javier Chinen; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2018-08-29       Impact factor: 10.793

Review 8.  Targeted Therapy with Biologicals and Small Molecules in Primary Immunodeficiencies.

Authors:  Ottavia Maria Delmonte; Luigi Daniele Notarangelo
Journal:  Med Princ Pract       Date:  2019-10-10       Impact factor: 1.927

Review 9.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

10.  Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

Authors:  Dimana Dimitrova; Juan Gea-Banacloche; Seth M Steinberg; Jennifer L Sadler; Stephanie N Hicks; Ellen Carroll; Jennifer S Wilder; Mark Parta; Lauren Skeffington; Thomas E Hughes; Jenny E Blau; Miranda M Broadney; Jeremy J Rose; Amy P Hsu; Rochelle Fletcher; Natalia S Nunes; Xiao-Yi Yan; William G Telford; Veena Kapoor; Jeffrey I Cohen; Alexandra F Freeman; Elizabeth Garabedian; Steven M Holland; Andrea Lisco; Harry L Malech; Luigi D Notarangelo; Irini Sereti; Nirali N Shah; Gulbu Uzel; Christa S Zerbe; Daniel H Fowler; Ronald E Gress; Christopher G Kanakry; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-04       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.